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Appendix 2: Newcastle-Ottawa scale for assessing the quality of cohort studies 
Study Selection Comparability Outcome Rating Quality 
  
 Information on 
age composition 
of childhood 
cohorts with 
information on 
BCG
a
 
 
Ascertainment 
of 
immunisation 
status
b
 
Demonstration 
that 
mycobacterium 
tuberculosis 
infection 
(determined by 
IGRA) was not 
present before the 
BCG immunisation 
was given
c
. 
Comparability of 
cohorts on the 
basis of the design 
or analysis
d
 
Assessment of 
infection with 
Mycobacterium 
tuberculosis by 
interferon 
gamma release 
assay
e
 
Was interferon 
gamma release 
assay done long 
enough after 
exposure for 
infection to be 
detectable in both 
immunized and not 
immunized groups
f
 
 Adequacy of 
follow up of 
children 
exposed to 
the patient 
with 
tuberculosis 
g
 
Overall 
Star 
Ratins 
Overall 
Rating= 
Star 
/9(%) 
Quality 
Adetifa et al 2010  B* B* B* B* D C C 4* 44 moderate 
Altet-Gomez et al  2011 A* B* C B* A* B B* 5* 55 moderate 
Bianchi et al 2009 A* B* C B* D C B* 4* 44 moderate 
Domingues et al 2008 B* B* C B* D C B* 4* 44 moderate 
Eisenhut et al 2009 B* B* C A*B* D C B* 5* 55 moderate 
Eriksen et al 2010  A* B* C A*B* D A* A* 6* 67 high 
Ewer et al 2003 B* B* C B* D C D 4* 44 moderate 
Hill et al 2011 B* B* C B* D C D 3* 33 low 
Neira-Munoz  et al 2008 A* B* C B* D C B* 4* 44 moderate 
Okada et al 2008 B* B* B* A*B* D A* A* 7* 77 high 
Rutherford et al 2012 A* B* C A* D C C 3* 33 low 
Soysal et al 2005 B* B* B* A*B* A* C B* 7* 77 high 
Tsiouris et al 2006 B* B* C B* D C B* 4* 44 moderate 
Tsolis et al 2010 C C C A*B* D C B* 3* 33 low 
a
A Mean or median age provided*; B Age range provided *; C No information on age 
b
A Secure immunisation record*; B BCG scar only or combination of good history and/or BCG scar and/or secure record *; C  Written self report; D No description 
c
A An IGRA test excluded infection with mycobacterium tuberculosis before BCG immunisation*; B BCG immunisation was given at birth as reported in publication*;  C No demonstration of lack of mycobacterium 
tuberculosis infection before BCG immunisation. 
d
A Study provided adjusted odds ratio by degree of exposure to infectious case and or age*; B    Study provided odds ratio of infection*;  C  Survey without knowledge of exposure. 
eA Assessent of infection status blind to BCG vaccination status or record linkage (blind to vaccination status) as reported in publication*; B Record linkage not blind to vaccination status or not described*;  C Self report; 
D No description 
f
A Yes (at least 6 weeks) after exposure to infectious patient with mycobacterium tuberculosis*; B No;  C  Information not provided 
g
A All children exposed were tested for infection*; B Similar losses to follow up in each group*;  C Some children not tested and no description who was affected or there was an indeterminate result in more than 10% 
and not equally distributed  ; D   No record of untested children or whether there were indeterminate results of testing 
